TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Centers Got $35 Million In NIH Construction $$; Send In Applications, Branch Chief Says July 24, 1992